Key result
RFCA achieves ~77% mid-term success for idiopathic non-outflow tract VAs after multiple procedures.
Why the study?
While catheter ablation is effective for outflow tract ventricular arrhythmias, data on the outcomes of catheter ablation for non-outflow tract ventricular arrhythmias are limited.
Does radiofrequency catheter ablation provide effective mid-term freedom from arrhythmias in patients with idiopathic non-outflow tract ventricular arrhythmias?
Cohort (n=251)
No
Does radiofrequency catheter ablation provide effective mid-term freedom from arrhythmias in patients with idiopathic non-outflow tract ventricular arrhythmias?
Catheter ablation is a feasible and effective treatment for idiopathic non-outflow tract ventricular arrhythmias, though arrhythmias originating from the papillary muscle or moderator band are associated with higher recurrence rates.
May support ablation for non-outflow tract VA in experienced centers; leaves open need for multicenter RCTs to confirm generalizability.
BACKGROUND: Catheter ablation is recommended in patients with frequent and symptomatic ventricular arrhythmias (VAs) in an otherwise normal heart. Right or left outflow tract (OT) are the most common origins, and catheter ablation is highly effective with low complication rates. However, outcome of catheter ablation of VAs other than the OT (non-OTVAs) is limited. The aim of this single-center study was to assess the safety and mid-term outcome of catheter ablation for non-OTVAs. METHOD AND RESULTS: From 2013 to 2018, 251 patients who underwent catheter ablation for idiopathic non-OTVAs were enrolled and grouped according to the origins including His-Purkinje system (HPS, n = 108), papillary muscle / moderator band (PM/MB, n = 47), tricuspid annulus (TA, n = 70), and mitral annulus (MA, n = 26), 244 (97.2%) had acute elimination of VAs. The time of VAs recurrence of the single procedure was 1.69 (0.12,9.72) months, with 66% occurring within the first 3 months. The recurrence rate was significantly higher in the PM/MB group than in the TA (p = 0.025) and MA groups (p = 0.023). The single procedure success rate in all patients was 70.1%, in which 66.7%, 59.6%, 80%, and 76.9% were achieved in the HPS, PM/MB, TA, and MA groups, respectively (p = 0.284). After multiple procedures, the total success rate was 76.5% at the follow-up of 4.38 ± 2.42 years. The rate was significantly lower in the PM/MB group than in the TA group (p = 0.035). In subgroup analysis, no significant difference was observed in the recurrence rate of single procedure in patients with different VA origins within the PM/MB (log-rank test, p = 0.546). CONCLUSION: Despite a certain percentage of recurrences observed in the mid-term follow-up, catheter ablation remained feasible and effective for idiopathic non-OTVAs.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2024) conducted a cohort in Idiopathic non-outflow tract ventricular arrhythmias (n=251). Radiofrequency catheter ablation was evaluated on Mid-term success rate after multiple procedures. Radiofrequency catheter ablation for idiopathic non-outflow tract ventricular arrhythmias achieved an acute success rate of 97.2% and a mid-term success rate of 76.5% after multiple procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: